Formaldehyde, a major industrial chemical, is classified as a carcinogen be
cause of its high reactivity with DNA. it is inactivated by oxidative metab
olism to formate in humans by glutathion-dependent formaldehyde dehydrogena
se. This NAD(+)-dependent enzyme belongs to the family of zinc-dependent al
cohol dehydrogenases with 40 kDa subunits and is also called ADH3 or chi-AD
H. The first step in the reaction involves the nonenzymatic formation of th
e S-(hydroxymethyl)glututhione adduct from formaldehyde and glutathione. Wh
en formaldehyde concentrations exceed that of glutathione, nonoxidizable ad
ducts can be formed in vitro. The S-(hydroxymethyl)glutathione adduct will
be predominant in vivo, since circulating glutathione concentrations are re
ported to be 50 times that of formaldehyde in humans. Initial velocity, pro
duct inhibition, dead-end inhibition, and equilibrium binding studies indic
ate that the catalytic mechanism for oxidation of S-(hydroxymethyl)glutathi
one and 12-hydroxydodecanoic acid (12-HDDA) with NAD(+) is random bi-bi. Fo
rmation of an E.NADH.12-HDDA abortive complex was evident from equilibrium
binding studies, but no substrate inhibition was seen with 12-HDDA. 12-Oxod
odecanoic acid (I2-ODDA) exhibited substrate inhibition, which is consisten
t with a preferred pathway for substrate addition in the reductive reaction
and formation of an abortive E.NAD(+).12-ODDA complex. The random mechanis
m is consistent with the published three-dimensional structure of the forma
ldehyde dehydrogenase.NAD(+) complex, which exhibits a unique semi-open coe
nzyme-catalytic domain conformation where substrates can bind or dissociate
in any order.